Dose Reduction Of Tocilizumab In Rheumatoid Arthritis Patients With Low Disease Activity Is Feasible

被引：0
|
作者：
van Herwaarden, Noortje [1 ]
Herfkens-Hol, Susan [1 ]
van der Maas, Aatke [1 ]
van Den Bemt, Bart J. F. [1 ]
van Vollenhoven, Ronald F. [2 ]
Bijlsma, Johannes W. J. [3 ]
den Broeder, Alfons A. [1 ]
机构：
[1] Sint Maartensklin, Nijmegen, Netherlands
[2] Karolinska Inst, Stockholm, Sweden
[3] Univ Med Ctr Utrecht, Utrecht, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2327
引用
收藏
页码：S992 / S992
页数：1
相关论文
共 50 条
  • [1] Dose reduction of tocilizumab in rheumatoid arthritis patients with low disease activity
    van Herwaarden, N.
    Herfkens-Hol, S.
    van der Maas, A.
    van den Bemt, B. J. F.
    van Vollenhoven, R. F.
    Bijlsma, J. W. J.
    den Broeder, A. A.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (03) : 390 - 394
  • [2] DOSE REDUCTION OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH LOW DISEASE ACTIVITY: A PILOT STUDY
    van Herwaarden, N.
    Herfkens-Hol, S.
    van der Maas, A.
    van den Bemt, B.
    van Vollenhoven, R.
    Bijlsma, J.
    den Broeder, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 886 - 886
  • [3] SUSTAINABLE LOW DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: REAL-WORLD EXPERIENCE WITH TOCILIZUMAB
    Shivacheva, T.
    Georgiev, T.
    Hristova, S.
    Dimitrov, S.
    Bogdanova-Petrova, S.
    Gerganov, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1138 - 1138
  • [4] Effect of Dose Escalation of Subcutaneous Tocilizumab on Disease Activity in Patients with Rheumatoid Arthritis in a Randomized Controlled Trial
    Singer, Nora G.
    Mohan, Shalini V.
    Yourish, Jeffrey
    Han, Jian
    Edwardes, Michael
    Michalska, Margaret
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [5] EFFECT OF DOSE ESCALATION OF SUBCUTANEOUS TOCILIZUMAB ON DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN A RANDOMIZED CONTROLLED TRIAL
    Singer, N.
    Mohan, S.
    Han, J.
    Edwardes, M.
    Michalska, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1126 - 1126
  • [6] Low immunogenicity of tocilizumab in patients with rheumatoid arthritis
    Burmester, Gerd R.
    Choy, Ernest
    Kivitz, Alan
    Ogata, Atsushi
    Bao, Min
    Nomura, Akira
    Lacey, Stuart
    Pei, Jinglan
    Reiss, William
    Pethoe-Schramm, Attila
    Mallalieu, Navita L.
    Wallace, Thomas
    Michalska, Margaret
    Birnboeck, Herbert
    Stubenrauch, Kay
    Genovese, Mark C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (06) : 1078 - 1085
  • [7] Dose Modification of Subcutaneous Tocilizumab in Patients with Rheumatoid Arthritis
    Best, Jennie H.
    Abbass, Ibrahim
    Tominna, Lenore
    Reiss, William
    [J]. AMERICAN HEALTH AND DRUG BENEFITS, 2020, 13 (02): : 72 - 73
  • [8] NON-MEDICAL SWITCHING FROM TOCILIZUMAB TO SARILUMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH LOW DISEASE ACTIVITY
    Den Broeder, N.
    Den Broeder, A.
    Verhoef, L. M.
    Van den Hoogen, F.
    Van der Maas, A.
    Van den Bemt, B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 593 - 594
  • [9] Decrease of Tocilizumab Dose in Patients with Rheumatoid Arthritis: A Pilot Study
    Fechtenbaum, Marie
    Lasselin-Boyard, Pauline
    Salomon, Sarah
    Jelin, Germain
    Millot, Florence
    Grados, Franck
    Fardellone, Patrice
    Goeb, Vincent
    [J]. PHARMACOLOGY, 2016, 98 (1-2) : 73 - 78
  • [10] Dose Modification of Subcutaneous Tocilizumab in Patients with Rheumatoid Arthritis Response
    Punekar, Rajeshwari
    Choi, Jeannie
    Boklage, Susan H.
    Iglesias-Rodriguez, Melitza
    Nola, Kamala
    [J]. AMERICAN HEALTH AND DRUG BENEFITS, 2020, 13 (02): : 73 - 73
12345